Compounds : Actualité Compounds en direct - P2 | Bourse Reflex
Accueil > Tags > Compounds

  • Toutes les actualités en rapport avec « Compounds »

03/06 14:00 Compounds - Apricus Bio CEO to Present Commercialization Plans for Vitaros(R) at Jefferies 2011 Global Healthcare Conference

31/05 16:50 Compounds - Apricus Biosciences Announces Issuance of Key Patent for RayVa(TM) for Raynaud's Phenomenon in Israel

27/05 11:00 Compounds - Apricus Biosciences' CEO to Present at Jefferies 2011 Global Healthcare Conference

24/05 08:55 Compounds - Apricus Biosciences to Present at the Euro-Biotech Partnering Forum 2011 to Further Its Partnership Efforts

20/05 16:10 Compounds - Apricus Biosciences Will Request Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland, Based on Guidance From Swiss Regulatory Authorities

20/05 16:00 Compounds - Apricus Biosciences CEO is Interviewed on CDTV.net

19/05 14:45 Compounds - Apricus Biosciences Receives Guidance From Swiss Regulatory Authorities Regarding Filing for Market Authorization of Vitaros(R) for Erectile Dysfunction in Switzerland

10/05 15:55 Compounds - Apricus Biosciences Announces First Quarter 2011 Financial Results Conference Call

28/04 16:10 Compounds - Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe

28/04 11:05 Compounds - Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe

28/04 09:30 Compounds - Apricus Biosciences to Present at the FSX Investor Conference in San Francisco on April 28, 2011

15/04 09:00 Compounds - Eurofins pioneers Allergen multi-screening in a single analysis

13/04 19:45 Compounds - Apricus Biosciences Files for Orphan Drug Designation for RayVa(TM)

05/04 18:55 Compounds - Apricus Biosciences' CEO Interviewed by WallStreetCorner.com

31/03 16:45 Compounds - Apricus Biosciences Expands Patent Coverage in Mexico for Its Erectile Dysfunction Drug, Vitaros(R)

24/03 15:55 Compounds - Apricus Biosciences Adopts Shareholder Rights Plan

22/03 14:55 Compounds - Apricus Biosciences Announces Poster Presentations on Progress of PrevOnco(TM) in Combination With NexACT(R) Technology at the American Association for Cancer Research 2011 Annual Meeting

15/03 15:30 Compounds - Apricus Biosciences Announces Formation of Clinical Advisory Board as Part of Its Plans to Further the Clinical Development of Femprox(R)

14/03 09:30 Compounds - Lancement de Sativex(R) en Espagne pour traiter l'hypertonie spastique dans les cas de sclérose en plaques (SEP)

10/03 16:00 Compounds - Apricus Biosciences to Present at the Bio-Europe Spring 2011 Conference